RT Journal Article
SR Electronic
T1 Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004335
DO 10.1136/jitc-2021-004335
VO 10
IS 3
A1 van Vloten, Jacob P
A1 Matuszewska, Kathy
A1 Minow, Mark A A
A1 Minott, Jessica A
A1 Santry, Lisa A
A1 Pereira, Madison
A1 Stegelmeier, Ashley A
A1 McAusland, Thomas M
A1 Klafuric, Elaine M
A1 Karimi, Khalil
A1 Colasanti, Joseph
A1 McFadden, D Grant
A1 Petrik, James J
A1 Bridle, Byram W
A1 Wootton, Sarah K
YR 2022
UL http://jitc.bmj.com/content/10/3/e004335.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.